Administration of nicotinamide riboside in a mice model of cardiomyopathy, that lacks transferrin receptor protein 1 (TfR1) in the heart, resulted in prevention of cardiomegaly, mitochondrial respiration poor cardiac function, and impaired mitophagy (Xu W et al. 2015). This evidence concerns the gene TFRC and cardiomyopathy.